IRIS
BIANCHI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 914
EU - Europa 413
AS - Asia 132
AF - Africa 12
Totale 1.471
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 913
IT - Italia 102
UA - Ucraina 74
IE - Irlanda 62
SE - Svezia 60
CN - Cina 56
DE - Germania 36
SG - Singapore 35
TR - Turchia 24
DK - Danimarca 22
GB - Regno Unito 19
FI - Finlandia 15
BE - Belgio 14
KR - Corea 14
CI - Costa d'Avorio 12
NL - Olanda 4
IN - India 3
AT - Austria 2
CA - Canada 1
HR - Croazia 1
RO - Romania 1
RU - Federazione Russa 1
Totale 1.471
Salva come PNG Salva come JPEG
Città #
Chandler 175
Jacksonville 84
Ashburn 69
Ann Arbor 68
Fairfield 66
Dublin 57
Boardman 45
New York 41
Woodbridge 39
Wilmington 34
Houston 27
Cambridge 24
Seattle 22
Lawrence 20
Princeton 20
Ancona 19
Des Moines 18
San Mateo 18
Singapore 15
Abidjan 12
Brussels 11
Centro 11
San Diego 11
Tolentino 11
Beijing 9
Turin 9
Cascina 5
Redmond 5
Cupra Marittima 4
Falconara Marittima 4
Ningbo 4
Xi'an 4
Guangzhou 3
Helsinki 3
London 3
Norwalk 3
Shanghai 3
Washington 3
Wuhan 3
Amsterdam 2
Citta 2
Clifton 2
Como 2
Los Angeles 2
Pune 2
Redwood City 2
Torre Del Greco 2
Vienna 2
Waanrode 2
Yiwu 2
Zibo 2
Burlington 1
Campogalliano 1
Cattolica 1
Chengdu 1
Grünwald 1
Hangzhou 1
Jiaxing 1
Kilburn 1
Liberty Lake 1
Limerick 1
Marche 1
Mondolfo 1
Ottawa 1
Phoenix 1
Prescot 1
Qingdao 1
Quanzhou 1
Saint Petersburg 1
San Jose 1
Seoul 1
Shenzhen 1
Trecastelli 1
Villa Verucchio 1
Waterloo 1
Weitang 1
Woodhall Spa 1
Wuxi 1
Totale 1.033
Salva come PNG Salva come JPEG
Nome #
'Secrets and lies'--the difficulties of communicating within families with inherited cancer syndromes. 91
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy. 89
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy 89
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 87
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. 82
An intronic mutation in MLH1 associated with familial colon and breast cancer. 82
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival 81
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. 80
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal? 77
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 75
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 72
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 67
MSH2 splice site mutation and endometrial cancer. 65
MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system 60
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors 60
Insulin-like Growth Factor (IGF) 1 and 2 help to predict disease outcome in GIST patients 59
Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC. 57
Beta-catenin gene analysis in oral squamous cell carcinoma. 54
KIT and PDGFR(alpha) mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study. 48
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 46
null 31
Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine 19
miRNA signature as early predictor of hyponatremia and survival in lung cancer: preliminary results from the ISA retrospective study 17
1621P miRNA signature as early predictor of hyponatremia and survival in lung cancer: Preliminary results from the ISA retrospective study 13
BRCA mutations and gastrointestinal cancers: When to expect the unexpected? 4
Totale 1.505
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.921
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020123 1 3 13 1 25 3 16 3 19 3 10 26
2020/2021330 17 38 54 9 29 15 25 23 32 34 35 19
2021/2022182 5 36 3 3 20 11 8 12 19 20 12 33
2022/2023421 28 62 21 44 41 59 0 21 77 7 53 8
2023/2024251 30 7 17 22 40 54 2 3 1 3 3 69
2024/202562 62 0 0 0 0 0 0 0 0 0 0 0
Totale 1.505